共 14 条
- [1] CIRCUMVENTION OF DAUNORUBICIN (DNR) RESISTANCE IN EHRLICH ASCITES TUMOR (EHR/DNR+) INVITRO BY ANTHRACYCLINE ANALOGS [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1987, 28 : 282 - 282
- [3] INCREASE IN ADSORPTIVE ENDOCYTOSIS IN ANTHRACYCLINE AND VINCA ALKALOID RESISTANT EHRLICH ASCITES TUMOR-CELLS (EHR) [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1986, 27 : 269 - 269
- [5] OVERCOMING VINCA ALKALOID (VA) AND ANTHRACYCLINE (ANTH) RESISTANCE IN HUMAN-LEUKEMIA CELLS [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1984, 25 (MAR): : 334 - 334
- [8] CROSS RESISTANCE BETWEEN VINCA ALKALOIDS AND ANTHRACYCLINES IN EHRLICH ASCITES TUMOR IN-VIVO [J]. CANCER CHEMOTHERAPY REPORTS PART 1, 1972, 56 (06): : 701 - 708
- [10] ACTIVE-DRUG EFFLUX IN DAUNORUBICIN (DNR) RESISTANT EHRLICH ASCITES TUMOR-CELLS (EHR) IS INHIBITED BY THE CARBOXYLIC IONOPHORE MONENSIN [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1987, 28 : 294 - 294